Home Tags UBS analyst Eliana Merle

Tag: UBS analyst Eliana Merle

Archives

CureVac is an Underappreciated Opportunity, Says UBS

admin -
0
Investors may want to keep an eye on CureVac (CVAC). After pulling back from about $12.50 to $10.50, CVAC could see higher highs.  In fact,...

Popular Post

© Weekly Stock Watch Copyright © 2020
quit

Get Your Free Actionable Chart of Day Now

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.


*by submitting your information you agree to the terms of our Privacy Policy. You will receive FWeekly Stock Watch email and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.